A new diagnostic entity with potential clinical implications

Pathology/Molecular biology / Lung and other thoracic tumours / Anticancer agents & Biologic therapy
In a large number of samples of lung adenocarcinoma the incidence of RET fusion, as detected by routine diagnostics, was higher than expected, according to a report by Dr Oliver Gautschi of the Clinic for Oncology, Kantonsspital, Luzern, Switzerland presented during a proffered papers session at the 4th European Lung Cancer Conference (26-29 March 2014, Geneva, Switzerland).

To read the rest of this story visit the ESMO site.